Stock Analysis

Private equity firms who hold 63% of Kora Saúde Participações S.A. (BVMF:KRSA3) gained 18%, insiders profited as well

BOVESPA:KRSA3
Source: Shutterstock

Key Insights

  • Significant control over Kora Saúde Participações by private equity firms implies that the general public has more power to influence management and governance-related decisions
  • The largest shareholder of the company is BRL Trust Investimentos Ltda. with a 63% stake
  • Insiders own 15% of Kora Saúde Participações

Every investor in Kora Saúde Participações S.A. (BVMF:KRSA3) should be aware of the most powerful shareholder groups. With 63% stake, private equity firms possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Following a 18% increase in the stock price last week, private equity firms profited the most, but insiders who own 15% stock also stood to gain from the increase.

Let's take a closer look to see what the different types of shareholders can tell us about Kora Saúde Participações.

See our latest analysis for Kora Saúde Participações

ownership-breakdown
BOVESPA:KRSA3 Ownership Breakdown December 22nd 2024

What Does The Institutional Ownership Tell Us About Kora Saúde Participações?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that Kora Saúde Participações does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Kora Saúde Participações, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
BOVESPA:KRSA3 Earnings and Revenue Growth December 22nd 2024

We note that hedge funds don't have a meaningful investment in Kora Saúde Participações. Our data shows that BRL Trust Investimentos Ltda. is the largest shareholder with 63% of shares outstanding. With such a huge stake in the ownership, we infer that they have significant control of the future of the company. Antonio Benjamin Neto is the second largest shareholder owning 7.8% of common stock, and Bruno Moulin Machad holds about 7.1% of the company stock.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is some analyst coverage of the stock, but it could still become more well known, with time.

Insider Ownership Of Kora Saúde Participações

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

It seems insiders own a significant proportion of Kora Saúde Participações S.A.. It has a market capitalization of just R$611m, and insiders have R$91m worth of shares in their own names. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public-- including retail investors -- own 15% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Private Equity Ownership

With an ownership of 63%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Kora Saúde Participações better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Kora Saúde Participações , and understanding them should be part of your investment process.

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Valuation is complex, but we're here to simplify it.

Discover if Kora Saúde Participações might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.